Pharmacological assessment of efavirenz weight-band dosing recommendations in HIV-infected thai children

Pharmacological assessment of efavirenz weight-band dosing recommendations in HIV-infected thai children

[No abstract available]

محفوظ في:

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Cressey T.R., Aurpibul L., Narkbunnam T., Sirisanthana V., Phongsamart W., Oberdorfer P., Lapphra K., Sudjaritruk T., Chokephaibulkit K.
التنسيق:	Letter
اللغة:	English
منشور في:	2014
الوصول للمادة أونلاين:	http://www.scopus.com/inward/record.url?eid=2-s2.0-84872083154&partnerID=40&md5=9b5df0fc0eb6262cbbe62cfffae54734 http://cmuir.cmu.ac.th/handle/6653943832/4020
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
المؤسسة:	Chiang Mai University
اللغة:	English

مواد مشابهة

Pharmacological assessment of efavirenz weight-band dosing recommendations in HIV-infected thai children
بواسطة: Tim R. Cressey, وآخرون
منشور في: (2018)

Pharmacological assessment of efavirenz weight-band dosing recommendations in HIV-infected thai children
بواسطة: Tim R. Cressey, وآخرون
منشور في: (2018)

Pharmacological assessment of efavirenz weight-band dosing recommendations in HIV-infected thai children
بواسطة: Tim R. Cressey, وآخرون
منشور في: (2018)

Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing
بواسطة: Linda Aurpibul, وآخرون
منشور في: (2018)

Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing
بواسطة: Linda Aurpibul, وآخرون
منشور في: (2018)

Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing
بواسطة: Linda Aurpibul, وآخرون
منشور في: (2018)

Plasma efavirenz concentrations and the association with CYP2B6-516G>T polymorphism in HIV-infected Thai Children
بواسطة: Puthanakit T., وآخرون
منشور في: (2014)

Efavirenz concentrations and probability of HIV replication in children
بواسطة: Nontiya Homkham, وآخرون
منشور في: (2018)

Efavirenz concentrations and probability of HIV replication in children
بواسطة: Nontiya Homkham, وآخرون
منشور في: (2018)

Plasma efavirenz concentrations and the association with CYP2B6-516G>T polymorphism in HIV-infected Thai Children
بواسطة: Thanyawee Puthanakit, وآخرون
منشور في: (2018)

Plasma efavirenz concentrations and the association with CYP2B6-516G>T polymorphism in HIV-infected Thai Children
بواسطة: Thanyawee Puthanakit, وآخرون
منشور في: (2018)

Vitamin D status in perinatally HIV-infected Thai children receiving antiretroviral therapy
بواسطة: Aurpibul L., وآخرون
منشور في: (2017)

Does pregnancy affect the pharmacokinetics of efavirenz?
بواسطة: Hill A., وآخرون
منشور في: (2014)

Switching efavirenz to rilpivirine in virologically suppressed adolescents with HIV: a multi-centre 48-week efficacy and safety study in Thailand
بواسطة: Phongsamart W.
منشور في: (2023)

Erratum : Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight band dosing(Pediatr Infect Dis J. (2015)34(392-397))
بواسطة: Kulkanya Chokephaibulkit
منشور في: (2018)

Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children
بواسطة: Phongsamart W., وآخرون
منشور في: (2014)

Long-term outcome of nevirapine or efavirenz based antiretroviral regimens in mothers exposed to single dose nevirapine
بواسطة: Sripan,P., وآخرون
منشور في: (2015)

Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients
بواسطة: Bouazza N., وآخرون
منشور في: (2017)

A phase II/III trial of lopinavir/ritonavir dosed according to the WHO pediatric weight band dosing guidelines
بواسطة: Jorge A. Pinto, وآخرون
منشور في: (2018)

Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients
بواسطة: Naïm Bouazza, وآخرون
منشور في: (2018)

Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients
بواسطة: Naïm Bouazza, وآخرون
منشور في: (2018)

Vitamin D status in perinatally HIV-infected Thai children receiving antiretroviral therapy
بواسطة: Linda Aurpibul, وآخرون
منشور في: (2018)

Vitamin D status in perinatally HIV-infected Thai children receiving antiretroviral therapy
بواسطة: Linda Aurpibul, وآخرون
منشور في: (2018)

Pharmacokinetics of nevirapine in HIV and tuberculosis-coinfected children receiving antiretroviral fixed-dose combination tablets while receiving rifampicin-containing tuberculosis treatment and after rifampicin discontinuation
بواسطة: Prasitsuebsai W., وآخرون
منشور في: (2017)

Nevirapine exposure with WHO pediatric weight band dosing: Enhanced therapeutic concentrations predicted based on extensive international pharmacokinetic experience
بواسطة: Nikanjam M., وآخرون
منشور في: (2014)

Once- versus twice-daily lopinavir/ritonavir tablets in virologically suppressed, HIV-infected, treatment-experienced children: Comparative pharmacokinetics and virological outcome after switching to once-daily lopinavir/ritonavir
بواسطة: Chokephaibulkit K., وآخرون
منشور في: (2014)

Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin
بواسطة: W. Manosuthi, وآخرون
منشور في: (2018)

Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adults
بواسطة: Sukasem C., وآخرون
منشور في: (2014)

Switching efavirenz to rilpivirine in virologically suppressed adolescents with HIV: a multi-centre 48-week efficacy and safety study in Thailand
بواسطة: Wanatpreeya Phongsamart, وآخرون
منشور في: (2022)

Effect of efavirenz on the Pharmacokinetics of Ketoconazole in HIV-infected patients
بواسطة: Somchai Sriwiriyajan
منشور في: (2006)

Effect of efavirenz on the pharmacokinetics of ketoconazole in HIV-infected patients
بواسطة: Somchai Sriwiriyajan, وآخرون
منشور في: (2006)

Role of efavirenz plasma concentrations on long-term HIV suppression and immune restoration in HIV-infected children
بواسطة: Nontiya Homkham, وآخرون
منشور في: (2019)

Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children
بواسطة: Wanatpreeya Phongsamart, وآخرون
منشور في: (2018)

Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children
بواسطة: Wanatpreeya Phongsamart, وآخرون
منشور في: (2018)

Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescents
بواسطة: Watsamon Jantarabenjakul, وآخرون
منشور في: (2018)

Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescents
بواسطة: Watsamon Jantarabenjakul, وآخرون
منشور في: (2019)

Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children
بواسطة: Chokephaibulkit K., وآخرون
منشور في: (2014)

Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children
بواسطة: Chokephaibulkit K., وآخرون
منشور في: (2014)

Prevention and treatment of HIV infection in neonates: evidence base for existing WHO dosing recommendations and implementation considerations
بواسطة: Diana F. Clarke, وآخرون
منشور في: (2018)

Prevention and treatment of HIV infection in neonates: evidence base for existing WHO dosing recommendations and implementation considerations
بواسطة: Diana F. Clarke, وآخرون
منشور في: (2018)